DE3480599D1 - 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen. - Google Patents

1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.

Info

Publication number
DE3480599D1
DE3480599D1 DE8484306437T DE3480599T DE3480599D1 DE 3480599 D1 DE3480599 D1 DE 3480599D1 DE 8484306437 T DE8484306437 T DE 8484306437T DE 3480599 T DE3480599 T DE 3480599T DE 3480599 D1 DE3480599 D1 DE 3480599D1
Authority
DE
Germany
Prior art keywords
hydroxypyride
derivatives
pharmaceutical preparations
preparations containing
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484306437T
Other languages
German (de)
English (en)
Inventor
Robert Charles Hider
George Kontoghiorghes
Jack Silver
Michael Arthur Stockham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
NAT RES DEV
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NAT RES DEV, National Research Development Corp UK filed Critical NAT RES DEV
Application granted granted Critical
Publication of DE3480599D1 publication Critical patent/DE3480599D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE8484306437T 1983-09-23 1984-09-20 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen. Expired - Lifetime DE3480599D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838325496A GB8325496D0 (en) 1983-09-23 1983-09-23 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DE3480599D1 true DE3480599D1 (de) 1990-01-04

Family

ID=10549201

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484306437T Expired - Lifetime DE3480599D1 (de) 1983-09-23 1984-09-20 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.

Country Status (11)

Country Link
US (1) US4587240A (enExample)
EP (1) EP0138420B1 (enExample)
JP (2) JPS6094966A (enExample)
CY (1) CY1574A (enExample)
DE (1) DE3480599D1 (enExample)
DK (1) DK161703C (enExample)
GB (2) GB8325496D0 (enExample)
GR (1) GR80444B (enExample)
HK (1) HK7091A (enExample)
SG (1) SG93290G (enExample)
ZA (1) ZA847409B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
USRE34313E (en) * 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
US5010191A (en) * 1985-08-19 1991-04-23 The Regents Of The University Of California Imaging agents for in vivo magnetic resonance and scintigraphic imaging
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US4908371A (en) * 1987-11-10 1990-03-13 Ciba-Geigy Corporation Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload
GB8910521D0 (en) * 1989-05-08 1989-06-21 Nat Res Dev The stabilization of organic compounds
US5443813A (en) * 1991-06-06 1995-08-22 Associated Universities, Inc. Loading and conjugating cavity biostructures
EP0833627B1 (en) 1995-06-10 2004-08-18 Vitra Pharmaceuticals Ltd. Iron compounds, compositions, methods of making the same and uses thereof
US5667933A (en) * 1996-02-26 1997-09-16 Polaroid Corporation Image-recording element
GB9625638D0 (en) * 1996-12-10 1997-01-29 Cenes Ltd Therapeutic antioxidants for alzheimer's diease
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ATE538794T1 (de) 1999-01-13 2012-01-15 Bayer Healthcare Llc Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
US7135196B2 (en) * 2000-09-19 2006-11-14 Vitra Pharmaceuticals Limited Iron compositions
MXPA04007832A (es) 2002-02-11 2005-09-08 Bayer Pharmaceuticals Corp Aril-ureas con actividad inhibitoria de angiogenesis.
GB0211500D0 (en) * 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
US7595073B2 (en) * 2003-02-28 2009-09-29 Kraft Foods Global Brands Llc Use of siderophores and organic acids to retard lipid oxidation
EP1636585B2 (en) 2003-05-20 2012-06-13 Bayer HealthCare LLC Diaryl ureas with kinase inhibiting activity
HRP20060073B1 (hr) 2003-07-23 2014-03-14 Bayer Healthcare Llc Fluoro supstituirana omega-karboksiaril difenil urea za lijeäśenje i prevenciju bolesti i stanja
NZ600874A (en) 2007-03-28 2013-01-25 Apotex Technologies Inc Fluorinated derivatives of deferiprone
MX2010011701A (es) 2008-04-25 2010-12-06 Apotex Technologies Inc Formulacion liquida para deferiprona con gusto agradable al paladar.
PT2448922E (pt) 2009-07-03 2014-12-02 Apotex Technologies Inc Derivados fluorados de 3-hidroxipiridina-4-onas
JP5648120B2 (ja) 2010-03-23 2015-01-07 ヴィフォール （インターナショナル） アクチェンゲゼルシャフトＶｉｆｏｒ （Ｉｎｔｅｒｎａｔｉｏｎａｌ） ＡＧ 鉄欠乏症および鉄欠乏性貧血の治療および予防用の鉄（ｉｉｉ）錯体化合物
JP5923161B2 (ja) * 2011-03-29 2016-05-24 ヴィフォール （インターナショナル） アクチェンゲゼルシャフトＶｉｆｏｒ （Ｉｎｔｅｒｎａｔｉｏｎａｌ） ＡＧ 鉄欠乏症状および鉄欠乏性貧血の治療および予防のための鉄（ｉｉｉ）錯体化合物
WO2012163938A1 (de) 2011-05-31 2012-12-06 Vifor (International) Ag Fe(iii)-2,4-dioxo-1-carbonyl-komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien
KR20140143832A (ko) * 2012-04-05 2014-12-17 비포르 (인터내셔날) 아게 철 결핍 증상 및 철 결핍 빈혈의 치료 및 예방을 위한 Fe(III)-피라진 착화합물
CA2891572A1 (en) 2012-12-21 2014-06-26 Vifor (International) Ag Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2748142A (en) * 1956-05-29 - process of production
GB778871A (en) * 1955-02-14 1957-07-10 Sadolin & Holmblad As Pyridinediol oxides and acetates thereof and their preparation
GB790584A (en) * 1955-02-15 1958-02-12 Sadolin & Holmblad As Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series
GB791719A (en) * 1955-02-15 1958-03-12 Sadolin & Holmblad As Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series
FR3691M (fr) * 1963-05-06 1965-11-15 Olin Mathieson Nouvelle composition pharmaceutique utile en tant que fongicide.
NL156397B (nl) * 1968-08-31 1978-04-17 Hoechst Ag Werkwijze voor het bereiden van preparaten tegen schimmelaandoeningen, gevormde preparaten, alsmede werkwijze voor het bereiden van daarvoor geschikte actieve stoffen.
US3968118A (en) * 1968-08-31 1976-07-06 Hoechst Aktiengesellschaft Process for the manufacture of 1-hydroxy-2-pyridones
US3705943A (en) * 1969-07-18 1972-12-12 Olin Corp Dialkyltin salts of substituted pyridine-1-oxides as fungicides and bactericides
EG10850A (en) * 1972-03-25 1976-06-30 Hoechst Ag Process for the preparation of 1-hydroxy-pyridones
DE2705562A1 (de) * 1977-02-10 1978-08-17 Basf Ag Verfahren zur herstellung von pyridonen
US4358455A (en) * 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
JPS5832812A (ja) * 1981-08-21 1983-02-25 Lion Corp 毛髪化粧料
GB2118176B (en) * 1982-03-24 1985-12-04 Nat Res Dev Pharmaceutical compositions
GB2117766B (en) * 1982-03-24 1985-08-29 Nat Res Dev Pharmaceutical compositions
DE3278014D1 (en) * 1982-10-01 1988-02-25 Merck & Co Inc Aralkylaminoethanol heterocyclic compounds
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
US4698431A (en) * 1985-11-12 1987-10-06 The United States Of America As Represented By The United States Department Of Energy Hydroxypyridonate chelating agents

Also Published As

Publication number Publication date
EP0138420B1 (en) 1989-11-29
GB2146990B (en) 1987-05-20
HK7091A (en) 1991-02-01
JPH0566385B2 (enExample) 1993-09-21
EP0138420A2 (en) 1985-04-24
CY1574A (en) 1991-12-20
GR80444B (en) 1985-01-23
DK161703B (da) 1991-08-05
DK161703C (da) 1992-01-20
DK453584D0 (da) 1984-09-21
GB8325496D0 (en) 1983-10-26
JPS6094966A (ja) 1985-05-28
DK453584A (da) 1985-03-24
GB2146990A (en) 1985-05-01
JPH05246992A (ja) 1993-09-24
GB8423800D0 (en) 1984-10-24
JPH0811729B2 (ja) 1996-02-07
ZA847409B (en) 1986-05-28
EP0138420A3 (en) 1987-05-20
US4587240A (en) 1986-05-06
SG93290G (en) 1991-01-18

Similar Documents

Publication Publication Date Title
DE3480599D1 (de) 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.
FI844199A7 (fi) Lääkeainevalmiste.
ATE22007T1 (de) Pharmazeutische mischung.
DE3486255D1 (de) Pharmazeutische Zusammensetzungen.
DE3483133D1 (de) Pharmazeutische zusammensetzungen.
DE3685170D1 (de) Histaminderivate enthaltende pharmazeutische zusammensetzung.
IT8467535A1 (it) Preparazioni farmaceutiche aventi ridotta tossicità.
DE3485408D1 (de) Pharmazeutische zusammensetzung.
DE3484098D1 (de) Pharmazeutische zusammensetzungen.
DE3863678D1 (de) Lithiumsalze enthaltende pharmazeutische zubereitungen.
NO875419D0 (no) Blandinger for farmasoeytisk tape.
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
DE3682960D1 (de) Pharmazeutische praeparate.
DE3576118D1 (de) Pharmazeutische praeparate.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
NO874193D0 (no) Farmasoeytiske preparater.
FI881238A7 (fi) Farmaceutisk beredning.
DE3483900D1 (de) Pharmazeutische zusammensetzungen.
DE68902056D1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
IT8520591A0 (it) Formulazione farmaceutica.
FI822980A7 (fi) Furanokromonijohdannaisia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia valmisteita.
DE3667915D1 (de) Pharmazeutische zusammensetzung.
ATE64535T1 (de) Xylometazolinhaltige pharmazeutische praeparate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BRITISH TECHNOLOGY GROUP LTD., LONDON, GB

8339 Ceased/non-payment of the annual fee